Skip to content
Search

Latest Stories

Boots and Superdrug may start selling Covid-19 vaccines soon

Boots and Superdrug may start selling Covid-19 vaccines soon

The high street retailers are in discussions with suppliers to offer a private Covid vaccination service in 2024, in collaboration with the government.

Like the flu jab, Covid-19 vaccines may be available for purchase from pharmacies in Britain in the coming months.


Two high street retailers, Boots and Superdrug, have revealed to The Times that they are collaborating with the government to start selling Covid jabs, which are currently only available from the NHS.

A Superdrug spokesman told the publication that they are in discussions with suppliers about “potentially offering a private Covid vaccination service in 2024.”

Boots, which already offers a range of vaccinations, including flu for both private and NHS customers, is also assessing various ways on how to offer private Covid vaccinations, a company’s spokesman informed The Times.

Moderna and Pfizer, two of the largest producers of the jab, have expressed their interest in providing their product to private operators, the report stated.

Currently, the flu jab is available in pharmacies and private clinics for between £10 and £20. At what price a Covid vaccine could be sold by high street retailers is still unknown.

Earlier in 2023, Moderna’s chief executive, Stéphane Bancel said that they were planning to sell its vaccines for $130, which is around £100.

Meanwhile, several countries, including the US, UK, China, and India, have reported a spike in Covid cases in recent weeks, due to the influx of a new strain of Covid known as JN.1.

Scientists at Japan's top research institute Riken have warned that this new variant could cause global 'heart failure pandemic'.

They explained that the ACE2 receptors, which the coronavirus uses for entry into human cells, are 'very common' in the heart, suggesting that many people infected with the virus may suffer from 'reduced cardiac function'.

With cases of Covid infection increasing in England and Scotland, the UK Health Security Agency (UKHSA) has urged all those eligible to get their seasonal Covid-19 vaccine before the window closes on 31 January 2024.

Latest data from the Winter Covid-19 Infection Study estimated that approximately one in every 24 people could test Covid positive at the current time in England and Scotland.

The highest prevalence regionally was found in London, with high rates of infection in people aged 18 to 44 years.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less